-
Ep. 5: Hype vs Reality: The Future of Immunotherapy | 22 mins 1
In our final episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma, our experts discuss the future of immunotherapy, separating hype from reality and exploring the next frontier of cancer treatment.
From cellular therapies and personalised cancer vaccines to mRNA technology and biomarker-driven treatment selection, the panel examines the innovations that could reshape melanoma care over the next decade and the challenges that remain before these therapies become routine clinical practice.
Led by Prof Georgina Long AO, the panel of experts discuss:- why melanoma continues to lead the global immunotherapy revolution
- the promise and limitations of TIL therapy, TCR-T cells and other cellular therapies
- how mRNA technology could transform cancer treatment beyond vaccines
- the rise of personalised cancer vaccines
- why biomarkers will be critical to the future of precision immunotherapy
If you missed our earlier episodes, take a look here or search "Melanoma Insights" in Spotify or your favourite podcast app.
This special edition vodcast from "Melanoma Insights for Professionals" is suitable for Medical Oncologists, Oncology Nurses and other health professionals. SPEAKERS
Prof Georgina Long AO
Medical Oncologist
Melanoma Institute Australia and The University of Sydney
Declaration of Interest
A/Prof Alexander Menzies
Medical Oncologist
Melanoma Institute Australia and The University of Sydney
Declaration of Interest
A/Prof Ines Silva
Medical Oncologist
Melanoma Institute Australia
Declaration of Interest
A/Prof Matteo Carlino
Medical Oncologist
Melanoma Institute Australia and The University of Sydney
Declaration of Interest
Please note that this presentation was accurate at the time of recording (April 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
This special vodcast is an initiative of Melanoma Institute Australia and made possible by an unrestricted educational grant from Bristol Myers Squibb.
-
Ep. 5: Hype vs Reality: The Future of Immunotherapy | 22 minsModule1.122 min
This content is for members only and you'll need to log in to view it. If you’re not a member, please register now.
